primary monoclonal rabbit anti-stathmin antibody (Spring Bioscience)
Structured Review

Primary Monoclonal Rabbit Anti Stathmin Antibody, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary monoclonal rabbit anti-stathmin antibody/product/Spring Bioscience
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Stathmin involvement in the maternal embryonic leucine zipper kinase pathway in glioblastoma"
Article Title: Stathmin involvement in the maternal embryonic leucine zipper kinase pathway in glioblastoma
Journal: Proteome Science
doi: 10.1186/s12953-016-0094-9
Figure Legend Snippet: Proteomics analysis of differentially expressed proteins in U87MG transfected with siRNA for MELK compared with U87MG transfected with non-target control. a Representative two-dimensional electrophoresis gels (2DE). Protein extracts (200 μg) were applied to 2DE using IPG pH 3-10NL (7 cm) for isoelectric focusing and 12.5 % SDS-PAGE mini gels as a second dimension. Gel image analysis was performed using ImageMaster 2D Platinum v.7.0 software. The arrows indicate selected protein spots from mass spectrometry analysis. b Proteins differentially expressed (up-regulated and downregulated) in the glioma cell line U87MG transfected with siRNA for MELK compared with U87MG cells transfected with non-target control (NTC). The expression levels of 12 differentially expressed protein spots were quantified on the basis of the normalised volume of the 2DE spots (% vol) for each group. These data were analysed via ANOVA (p < 0.05). The data are reported as the mean ± SD. One of the proteins, Stathmin (STMN1), exhibited lower expression levels when MELK was silenced
Techniques Used: Transfection, Electrophoresis, SDS Page, Software, Mass Spectrometry, Expressing
Figure Legend Snippet: MELK and stathmin protein expression in non-neoplastic and astrocytoma tissue samples. Immunohistochemistry was performed for MELK a – f and stathmin ( g – l ) in 6 cases each of in ( a and g ) non-neoplastic (NN) brain tissues, ( b and h ) pilocytic (AGI), ( c and i ) low grade (AGII), ( d and j ) anaplastic (AGIII) astrocytomas, and ( e and k ) glioblastoma (GBM). Pictures show representative cases of each sample type, with 400-x magnification. The bar ( k ) represent the scale bar of 10 μm. The graphs ( f and l ) represent a semi-quantitative immunolabelling score (ILS) calculated as the product of staining intensity and the percentage of positive cells. Both MELK and stathmin showed positive staining in the cytosol. MELK reactivity increased with the increment of the malignancy among diffusely infiltrating astrocytomas (AGII-AGIV). Stathmin cytosol staining was stronger in GBM cases. The horizontal bars show the median ILS of each group
Techniques Used: Expressing, Immunohistochemistry, Staining
Figure Legend Snippet: Effect of MELK and STMN1 knockdown with siRNA in GBM cell line. MELK and STMN1 expression levels relative to non-targeting control (NTC) were analyzed two days after transfection of U87MG cell line a The data show the average of two independent experiments and the vertical bar represents the standard deviations. Western blot of MELK and stathmin were analyzed after trasfection with siRNA for both genes and NTC ( b )
Techniques Used: Expressing, Transfection, Western Blot
Figure Legend Snippet: MELK and stathmin signaling. MELK can induce stathmin expression through two transcription factors, p53 and FOXM1. A tyrosine kinase receptor (TKR) is activated by phosphorylation after binding to a ligant. Growth factor receptor-bound protein 2 (GRB2) binds to the phophorylated residue of TKR and to Son of Sevenless homologs (SOS). GRB/SOS complex activates phosphoinositide 3-kinase (PI3K) and RAS-MAPK signaling pathways. Activation of mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) signaling pathways results in phosphorylation of stathmin on serine sites and consequent microtubule stability and cell cycle progression. Stathmin may be dephosphorylated by protein phosphatase 1 (PP1), protein phosphatase 2A (PP2A) and protein phosphatase 2B (PP2B), resulting in microtubule instability. TKR: tyrosine kinase receptor; P: phosphorylation
Techniques Used: Expressing, Binding Assay, Activation Assay
Figure Legend Snippet: Protein identification by MALDI-TOF-TOF MS of tryptic peptides obtained from 2DE spots of siRNA-NTC- and siRNA- MELK -transfected cells
Techniques Used: Transfection